| Category | Funding IC | Project Number | Sub Project # | Project Title | PI Name | Org Name | State / Country | Amount |
|
Tuberculosis Vaccine
|
NIAID
|
5R01AI067731-03
|
|
Antigen-specific CD8+ T cells and protective immunity to tuberculosis
|
BEHAR, SAMUEL
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$393,521
|
|
Tuberculosis Vaccine
|
NIAID
|
5R01AI068413-03
|
|
A TB Vaccine for AIDS Patients
|
HORWITZ, MARCUS
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$655,618
|
|
Tuberculosis Vaccine
|
NIAID
|
5R01AI015495-26
|
|
Dietary Deficiencies and Tuberculosis Vaccine Efficacy
|
MCMURRAY, DAVID
|
TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR
|
TX
|
$270,678
|
|
Tuberculosis Vaccine
|
NIAID
|
5R01AI059667-05
|
|
Type I Interferons in Immunity to Tuberculosis
|
ERNST, JOEL
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$392,994
|
|
Tuberculosis Vaccine
|
NIAID
|
5R01AI044373-09
|
|
Human T Cell Antigens of Mycobacterium tuberculosis
|
REED, STEVEN
|
INFECTIOUS DISEASE RESEARCH INSTITUTE
|
WA
|
$470,628
|
|
Tuberculosis Vaccine
|
NIAID
|
5R37AI026170-20
|
|
Molecular Genetic Analysis of Mycobacterium tuberculosis
|
JACOBS, WILLIAM
|
YESHIVA UNIVERSITY
|
NY
|
$419,399
|
|
Tuberculosis Vaccine
|
NIAID
|
5K08AI064229-04
|
|
Modeling latent TB Infection
|
KARAKOUSIS, PETROS
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$139,320
|
|
Tuberculosis Vaccine
|
NIAID
|
5R01AI069161-03
|
|
Anti-tuberculosis vaccination: The role of macrophages
|
NORTH, ROBERT
|
TRUDEAU INSTITUTE, INC.
|
NY
|
$375,067
|
|
Tuberculosis Vaccine
|
NIAID
|
5R01AI058810-05
|
|
Vaccination strategies against pulmonary tuberculosis
|
RAMSAY, ALISTAIR
|
LOUISIANA STATE UNIV HSC NEW ORLEANS
|
LA
|
$198,126
|
|
Tuberculosis Vaccine
|
NIAID
|
1R21AI073612-01A1
|
|
The role of regulatory T cells in M. tuberculosis infection
|
VANKAYALAPATI, RAMAKRISHNA
|
UNIVERSITY OF TEXAS HLTH CTR AT TYLER
|
TX
|
$196,875
|
|
Tuberculosis Vaccine
|
NIAID
|
5F31AI061836-04
|
|
Expression of MTB and Host Genes in Early Tuberculosis
|
ESTRELLA, JAYMIE
|
UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON
|
TX
|
$30,522
|
|
Tuberculosis Vaccine
|
NIAID
|
5R01AI065697-04
|
|
TB Vaccine Development in Nonhuman Primate Model
|
VANDEBERG, JOHN
|
SOUTHWEST FOUNDATION FOR BIOMEDICAL RES
|
TX
|
$790,437
|
|
Tuberculosis Vaccine
|
NIAID
|
1R43AI077163-01
|
|
Multiplex Microarray for Tuberculosis
|
AWDEH, ZUHEIR
|
PULSAR CLINICAL TECHNOLOGIES, INC.
|
MA
|
$120,209
|
|
Tuberculosis Vaccine
|
NIAID
|
5R01AI031338-16
|
|
Development and Testing of New Tuberculosis Vaccines
|
HORWITZ, MARCUS
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$690,878
|
|
Tuberculosis Vaccine
|
NIAID
|
5R01AI064494-03
|
|
Phage mimicry of mycobacterial signaling
|
HATFULL, GRAHAM
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$516,690
|
|
Tuberculosis Vaccine
|
NIAID
|
1R21AI078509-01
|
|
Acquired susceptibility to pulmonary TB
|
KORNFELD, HARDY
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
MA
|
$204,375
|
|
Tuberculosis Vaccine
|
NIAID
|
1R01AI072584-01A2
|
|
Mechanism of host cell apoptosis inhibition by Mycobacterium tuberculosis
|
BRIKEN, VOLKER
|
UNIVERSITY OF MARYLAND COLLEGE PK CAMPUS
|
MD
|
$143,751
|
|
Tuberculosis Vaccine
|
NIAID
|
5R01AI065653-04
|
|
Protective immunity induced by newborn BCG vaccination
|
HANEKOM, WILLEM
|
UNIVERSITY OF CAPE TOWN
|
SO AFR
|
$501,445
|
|
Tuberculosis Vaccine
|
NIAID
|
5R21AI071844-02
|
|
TLR2 Regulation of Host Immune Response in TB
|
SALGAME, PADMINI
|
UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL
|
NJ
|
$191,295
|
|
Tuberculosis Vaccine
|
NIAID
|
5R01AI076199-02
|
|
The Utility of Interferon-Gamma Release Assays in TB-HIV co-infected Children
|
MANDALAKAS, ANNA
|
CASE WESTERN RESERVE UNIVERSITY
|
OH
|
$544,343
|
|
Tuberculosis Vaccine
|
NIAID
|
1R03AI073469-01A1
|
|
Intracellular mycobacterial proteome
|
LI, QINGBO
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
IL
|
$78,500
|
|
Tuberculosis Vaccine
|
NIAID
|
2R01AI045658-06A2
|
|
Gene expression in M. tuberculosis
|
MCDONOUGH, KATHLEEN
|
WADSWORTH CENTER
|
NY
|
$373,462
|
|
Tuberculosis Vaccine
|
NIAID
|
1R01AI075038-01A2
|
|
Control of Immune responses by lipoxins during tuberculosis
|
ALIBERTI, JULIO
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
OH
|
$300,000
|
|
Tuberculosis Vaccine
|
NIA
|
5R01AG021097-05
|
|
CD8 T Cells and Immunity to Tuberculosis in Old Mice
|
TURNER, JOANNE
|
OHIO STATE UNIVERSITY
|
OH
|
$302,880
|
|
Tuberculosis Vaccine
|
NIAID
|
5R21AI072136-02
|
|
Thioesterase Inhibitors of Mycolic Acid Biosynthesis as Antitubercular Agents
|
ALDRICH, COURTNEY
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
MN
|
$219,989
|
|
Tuberculosis Vaccine
|
NIAID
|
5R01AI070219-03
|
|
Design of antituberculosis agents that target siderophore biosynthesis
|
ALDRICH, COURTNEY
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
MN
|
$284,812
|
|
Tuberculosis Vaccine
|
NIAID
|
5R01AI074824-02
|
|
Oxygen Sensors and P450 Monooxygenases in Mycobacertium tuberculosis
|
ORTIZ DE MONTELLANO, PAUL
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$401,130
|
|
Tuberculosis Vaccine
|
NCRR
|
5R01RR013601-10
|
|
Role of CD8 T cells in immunity to tuberculosis
|
CHEN, ZHENG
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
IL
|
$642,746
|
|
Tuberculosis Vaccine
|
NIAID
|
5U01AI070456-03
|
|
Response Therapies for MDR-TB
|
ORME, IAN
|
COLORADO STATE UNIVERSITY-FORT COLLINS
|
CO
|
$1,131,873
|
|
Tuberculosis Vaccine
|
NIAID
|
5R43AI075830-02
|
|
Optimization of a Multivalent Tuberculosis Vaccine
|
DE GROOT, ANNE
|
EPIVAX, INC.
|
RI
|
$285,475
|
|
Tuberculosis Vaccine
|
NIAID
|
5U01AI065663-04
|
|
US-Brazil Research Collaboration on Strain Variation in TB
|
ELLNER, JERROLD
|
UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL
|
NJ
|
$482,095
|
|
Tuberculosis Vaccine
|
NIAID
|
5R44AI052636-04
|
|
Screening Complete TB Proteome for Protective Antigens
|
GREENER, ALAN
|
GENE THERAPY SYSTEMS, INC.
|
CA
|
$676,839
|
|
Tuberculosis Vaccine
|
NHLBI
|
5R21HL092627-02
|
|
NK cells and IL-15 in the human innate immune response to tuberculosis
|
BARNES, PETER
|
UNIVERSITY OF TEXAS HLTH CTR AT TYLER
|
TX
|
$171,875
|
|
Tuberculosis Vaccine
|
NIAID
|
1R01AI076425-01A1
|
|
TB Vaccine Candidates Found in Patients' Bodily Fluids and Murine MHC-1 Molecule
|
CAMPOS-NETO, ANTONIO
|
FORSYTH INSTITUTE
|
MA
|
$609,083
|
|
Tuberculosis Vaccine
|
NIAID
|
2R01AI037859-11
|
|
Function of CD8 T Cells in Tuberculosis
|
FLYNN, JOANNE
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$324,298
|
|
Tuberculosis Vaccine
|
NIAID
|
4R00AI075106-02
|
|
Novel IL-17 producing memory cells are key to vaccine-based immunity in the lung
|
KHADER, SHABAANA
|
CHILDREN'S HOSP PITTSBURGH/UPMC HLTH SYS
|
PA
|
$249,000
|
|
Tuberculosis Vaccine
|
NIAID
|
1R43AI074176-01A2
|
|
ApoVax104-TB as a Novel Vaccine for Tuberculosis
|
MACLEOD, KATHRYN
|
APOIMMUNE, INC
|
KY
|
$391,672
|
|
Tuberculosis Vaccine
|
NHLBI
|
1F30HL094028-01
|
|
Immunosuppressive Role of TLR2 in Host Immunity to Mycobacterium tuberculosis
|
MCBRIDE, AMANDA
|
UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL
|
NJ
|
$29,660
|
|
Tuberculosis Vaccine
|
NIAID
|
2R01AI049534-06A2
|
|
Chracteristics of An M. Tuberculosis Derived Vaccine
|
JAGANNATH, CHINNASWAMY
|
UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON
|
TX
|
$354,475
|
|
Tuberculosis Vaccine
|
NHLBI
|
5P01HL076100-05
|
0003
|
Vaccination Strategies for Primary and Latent Pulmonary TB
|
RAMSAY, ALISTAIR
|
LOUISIANA STATE UNIV HSC NEW ORLEANS
|
LA
|
$388,050
|
|
Tuberculosis Vaccine
|
NIAID
|
5P01AI063537-04
|
0001
|
Genetic Approaches for Improving Tuberculosis Vaccines
|
JACOBS, WILLIAM
|
YESHIVA UNIVERSITY
|
NY
|
$315,517
|
|
Tuberculosis Vaccine
|
NIAID
|
5P01AI063537-04
|
0002
|
Determinants of T Cell Immunity to Tuberculosis Vaccines
|
PORCELLI, STEVEN
|
YESHIVA UNIVERSITY
|
NY
|
$316,829
|
|
Tuberculosis Vaccine
|
NIAID
|
5P01AI063537-04
|
0003
|
The Tuberculosis Granuloma
|
CHAN, JOHN
|
YESHIVA UNIVERSITY
|
NY
|
$316,632
|
|
Tuberculosis Vaccine
|
NIAID
|
2R44AI066442-02
|
|
Novel mycobacterial translocase I inhibitors - a new class of anti-TB drugs
|
REDDY, VENKATA
|
SEQUELLA, INC.
|
MD
|
$793,901
|
|
Tuberculosis Vaccine
|
FIC
|
4R00TW008043-03
|
|
Role of Mycobacterium tuberculosis protease in pathogenesis and host response
|
RENGARAJAN, JYOTHI
|
EMORY UNIVERSITY
|
GA
|
$225,000
|
|
Tuberculosis Vaccine
|
NIAID
|
3U54AI057157-06S1
|
0018
|
Innate Immune Responses to Pro-Apoptotic BCG
|
BRAUNSTEIN, MIRIAM
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$100,003
|
|
Tuberculosis Vaccine
|
NIAID
|
3U54AI057157-06S1
|
0019
|
Innate Immune Responses to Pro-Apoptotic BCG
|
KERNODLE, DOUGLAS
|
VANDERBILT UNIVERSITY
|
TN
|
$155,540
|
|
Tuberculosis Vaccine
|
NIGMS
|
5S06GM061223-08
|
0004
|
Mycothiol Associated Genes in ROI and RNI Stress Response
|
RAWAT, MAMTA
|
CALIFORNIA STATE UNIVERSITY FRESNO
|
CA
|
$225,764
|
|
Tuberculosis Vaccine
|
NIAID
|
N01AI40091-8-0-1
|
|
Tuberculosis Research Materials and Vaccine Testing
|
NO PI IDENTIFIED
|
COLORADO STATE UNIVERSITY-FORT COLLINS
|
CO
|
$515,844
|
|
Tuberculosis Vaccine
|
NCRR
|
5P51RR000169-47
|
5796
|
NONHUMAN PRIMATE MODEL FOR TB VACCINES
|
LUCIW, PAUL
|
UNIVERSITY OF CALIFORNIA DAVIS
|
CA
|
$53,655
|
|
Tuberculosis Vaccine
|
NIA
|
5P51RR000169-47
|
5796
|
NONHUMAN PRIMATE MODEL FOR TB VACCINES
|
LUCIW, PAUL
|
UNIVERSITY OF CALIFORNIA DAVIS
|
CA
|
$567
|
|
Tuberculosis Vaccine
|
NCRR
|
5P51RR013986-10
|
6316
|
TB VACCINE DEVELOPMENT IN NONHUMAN PRIMATE MODEL
|
VANDEBERG, JOHN
|
SOUTHWEST FOUNDATION FOR BIOMEDICAL RES
|
TX
|
$273,864
|
|
Tuberculosis Vaccine
|
NCRR
|
2P51RR000164-47
|
6462
|
DETERMINANTS OF PROTECTIVE IMMUNITY TO TUBERCULOSIS
|
KAUSHAL, DEEPAK
|
TULANE UNIVERSITY OF LOUISIANA
|
LA
|
$13,774
|
|
Tuberculosis Vaccine
|
NIA
|
2P51RR000164-47
|
6462
|
DETERMINANTS OF PROTECTIVE IMMUNITY TO TUBERCULOSIS
|
KAUSHAL, DEEPAK
|
TULANE UNIVERSITY OF LOUISIANA
|
LA
|
$123
|
|
Tuberculosis Vaccine
|
NCRR
|
2P51RR000164-47
|
6471
|
EFFICACY AND SAFETY OF LIVE ATTENUATED MYCOBACTERIUM TUBERCULOSIS VACCINES
|
LARSEN, MICHELLE
|
TULANE UNIVERSITY OF LOUISIANA
|
LA
|
$23,387
|
|
Tuberculosis Vaccine
|
NIA
|
2P51RR000164-47
|
6471
|
EFFICACY AND SAFETY OF LIVE ATTENUATED MYCOBACTERIUM TUBERCULOSIS VACCINES
|
LARSEN, MICHELLE
|
TULANE UNIVERSITY OF LOUISIANA
|
LA
|
$209
|
|
Tuberculosis Vaccine
|
NCRR
|
5M01RR000070-46
|
8026
|
DIABETES ON CYTOKINE RESPONSE TO BACILLE CALMETTE GUERIN VACCINATION
|
PARSONNET, JULIE
|
STANFORD UNIVERSITY
|
CA
|
$10,353
|
|
Tuberculosis Vaccine
|
NCRR
|
5M01RR000096-47
|
8548
|
IMMUNODIAGNOSTIC TESTS FOR THE RAPID DIAGNOSIS OF TB
|
ACHKAR, JACQUELINE
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$10,987
|
